Peer-influenced content. Sources you trust. No registration required. This is HCN.
Rare Disease Advisor
Maternal anti-HPA-1a antibodies inhibited β3 integrin activation in laboratory models, with stronger functional inhibition in severe FNAIT cases. The findings suggest a mechanism beyond platelet clearance, but clinical validation remains necessary.
Hematology August 31st 2026
Hematology Advisor
FcγRIII-mediated macrophage phagocytosis emerges as the dominant mechanism of platelet destruction in FNAIT, suggesting targeted receptor blockade could offer a future therapeutic approach, though evidence remains preclinical.
Hematology July 13th 2026
“Even a single amino acid mismatch between donor and recipient HLA can induce humoral response, influenced not just by sequence differences but also by structural and chemical properties.”
Hematology August 18th 2025
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS